ArticlePloS one2026
Capacity and site readiness for hypertension control program implementation in Nigeria: A nationwide cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits Model.Journal of clinical and translational science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study is to determine the capacity and readiness of Nigerian primary healthcare facilities to adopt a multi-level approach for the diagnosis, treatment, and control of hypertension.
methodsUsing a multi-stage sampling technique, 5 states were selected for the nationwide study, and 10 Primary Healthcare Centres (PHCs) were selected from each of the participating states. The 50 PHCs were evaluated using the World Health Organization-modified Service Availability and Readiness Assessment, focusing on the diagnosis and treatment of hypertension in Nigeria. The indicator scores for general and cardiovascular service preparedness were computed using the proportion of PHCs with accessible facilities, tools, diagnostic guidelines, and prescription drugs.
resultsA majority of PHCs (n = 43; 86%) reported having two or more full-time staff. The median number of full-time employees for the 50 PHCs was 6 (IQR = 2-9), and for the community health extension workers (CHEWs), the median was 2, the interquartile range (IQR) = 0-4. None of the PHCs had full-time physicians. Ninety-eight percent, 94%, and 84% of the 50 PHCs are able to provide screening services, diagnose, and confirm hypertension, respectively. In addition, 98% of the PHCs had functional blood pressure apparatus. However, only a minority of PHCs had the guidelines (24%), treatment algorithms (27%), and facilities. Most of the 50 PHCs (96%) use electronic patient records in their respective centres. Of the 50 PHCs studied, 66% had at least one 30-day antihypertensive treatment regimen in stock. The most commonly available drug classes were calcium channel blockers (72%), followed by diuretics (42%), central acting agents (38%), and angiotensin-converting enzyme inhibitors (36%). The median number of 30-day regimens in stock was 15 (IQR 0-132).
conclusionThis first large-scale systematic assessment of capacity and readiness for a system-level hypertension control program within five states of Nigeria demonstrated implementation feasibility based on the workforce, equipment, and health information systems, but there is a critical need for health-worker training and provision of protocols for hypertension treatment and control, as well as some need to strengthen the essential medicine supply chain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.